M. Peetermans - Concepedia

Author

M. Peetermans

Also Known As

C. Haanen, G. Visani, M E Peetermans, M Peetermans, M. E. PEETERMANS, M. E. Peetermans, M. PEETERMANS, M. Peetermans, M.E. Peetermans, Marc E. Peetermans

103

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Antwerp Antwerp University Hospital Institut Jules Bordet Radboud University Nijmegen Hôtel-Dieu de Paris

About

M. Peetermans is an author at University of Antwerp specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.4K
2	Health Sciences	9	9	741
3	Cell Biology	2	2	108
4	Public Health	1	1	10
5	Allergy	1	1	29

M. Peetermans

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia R Zittoun, Franco Mandelli, Roel Willemze, New England Journal of Medicine	1995	853
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. Bob Löwenberg, R Zittoun, H. Kerkhofs, Journal of Clinical Oncology Elderly PatientsMixed-phenotype Acute LeukemiaPharmacotherapyArm BMyeloid Neoplasia	1989	386
Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL‐6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL‐6 levels and febrile transfusion reactions L. Muylle, M. Joos, E. Wouters, Transfusion ImmunologyImmune RegulationPathologyBlood CellStored Platelet Concentrates	1993	367
Effect of Prestorage Leukocyte Removal on the Cytokine Levels in Stored Platelet Concentrates L. Muylle, M. Peetermans Vox Sanguinis	1994	165
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial R Zittoun, Stefan Suciu, Maggie Watson, Bone Marrow Transplantation Hematological MalignancyQuality Of LifeTransplantationMarrow TransplantationEortc-gimema Aml 8A	1997	130
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. R Zittoun, Stefan Suciu, Franco Mandelli, Journal of Clinical Oncology	1996	122
Reactions to platelet transfusion: the effect of the storage time of the concentrate L. Muylle, E. Wouters, R. De Bock, Transfusion Medicine	1992	121
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). T.J.M. de Witte, Stefan Suciu, M. Peetermans, PubMed	1995	121
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes Guido Tricot, R. De Bock, A. W. Dekker, British Journal of Haematology ImmunologyPathologyPharmacotherapyImmunotherapyMyeloid Neoplasia	1984	108
Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet‐rich plasma method L. Muylle, E. Wouters, M. Peetermans Transfusion	1996	99

Page 1